Thiamine Hydrochloride Injection, Solution
Product Images NDC 25021-500

2 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Thiamine Hydrochloride (NDC 25021-500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Thi01 0001 01)

Structural Formula (Thi01 0001 01)
Chemical structure of thiamine hydrochloride, showing its molecular components including a pyrimidine ring, a thiazole ring, and the associated hydrochloride group.*
FDA Label Image

Thi01 0002 02

Thi01 0002 02
Thiamine HCl Injection, USP label showing 200 mg per 2 mL (100 mg per mL) solution for intramuscular or intravenous use. The label indicates a 2 mL multi-dose vial manufactured for Sagent Pharmaceuticals, Schaumburg, IL, made in India. Includes NDC 25021-500-02 and barcode, with spaces for lot and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.